Nucelion Therapeutics, VeGen Bio Partner on CAR-T Therapy The Story: Nucelion Therapeutics and VeGen Bio have partnered to transfer technology and manufacture VL-2511, a Phase II dual-target CAR-T the...
Peptris Technologies Secures ₹86 Crore for AI-Discovered Drug Candidates The Story: Peptris Technologies has secured ₹86 crore under India’s RDI Fund to advance four AI-discovered drug candidates thro...
AstraZeneca’s Camizestrant Clears India’s SEC Review The Story: AstraZeneca’s camizestrant has received a positive SEC recommendation in India for HR-positive, HER2-negative advanced breast cancer wit...
Eisai Launches Leqembi in India for Early Alzheimer’s Disease The Story: Eisai has launched Leqembi (lecanemab) in India after CDSCO approval, introducing the country’s first disease-modifying t...
